tm logo

Monitor this mark

View On USPTO

SMOFTRIVEN
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 16 May 2024

Last Applicant/ Owned by

Fresenius Kabi AG

Else-Kroener-Str. 1

Bad Homburg

DE

61352

Serial Number

97698192 filed on 30th Nov 2022

Registration Number

N/A

Correspondent Address

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP

WASHINGTON, DC 20007

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SMOFTRIVEN

Pharmaceutical preparations, namely, infusion solutions for central intravenous nutritional therapy and infusion solutions for central intravenous parenteral nutrition

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely, infusion solutions for central intravenous nutritional therapy and infusion solutions for central intravenous parenteral nutrition

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97698192

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 034618.036B

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
21st Nov 2024SOU TEAS EXTENSION RECEIVED
17th May 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th May 2024SOU TEAS EXTENSION RECEIVED
16th May 2024SOU EXTENSION 2 GRANTED
16th May 2024SOU EXTENSION 2 FILED
24th Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd Nov 2023SOU EXTENSION 1 GRANTED
22nd Nov 2023SOU EXTENSION 1 FILED
22nd Nov 2023SOU TEAS EXTENSION RECEIVED
06th Jun 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT